Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?

C. Dickhoff; K. J. Hartemink; J. Kooij; P. M. van de Ven; M. A. Paul; E. F. Smit; M. Dahele

doi:https://doi.org/10.1093/annonc/mdw449

Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?

C. Dickhoff, K. J. Hartemink, J. Kooij, P. M. van de Ven, M. A. Paul, E. F. Smit, M. Dahele

Research output: Contribution to journal › Letter › Academic › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	185
Number of pages	1
Journal	Annals of Oncology
Volume	28
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdw449
Publication status	Published - 1 Jan 2017

Access to Document

https://doi.org/10.1093/annonc/mdw449

Cite this

@article{1314c0a659c2486ebbeb0363380c1c73,

title = "Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?",

author = "C. Dickhoff and Hartemink, {K. J.} and J. Kooij and {van de Ven}, {P. M.} and Paul, {M. A.} and Smit, {E. F.} and M. Dahele",

year = "2017",

month = jan,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdw449",

language = "English",

volume = "28",

pages = "185",

journal = "Annals of Oncology",

issn = "0923-7534",